{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:04:16Z","timestamp":1778857456788,"version":"3.51.4"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Anticoagulation therapy is standard for conditions like atrial fibrillation, venous thromboembolism, and valvular heart disease, yet it is unclear if there are ethnoracial disparities in its quality and delivery in the United States. For this scoping review, electronic databases were searched for publications between January 1, 2011 \u2013 March 30, 2022. Eligible studies included all study designs, any setting within the United States, patients prescribed anticoagulation for any indication, outcomes reported for\u2009\u2265\u20092 distinct ethnoracial groups. The following four research questions were explored: Do ethnoracial differences exist in 1) access to guideline-based anticoagulation therapy, 2) quality of anticoagulation therapy management, 3) clinical outcomes related to anticoagulation care, 4) humanistic\/educational outcomes related to anticoagulation therapy. A total of 5374 studies were screened, 570 studies received full-text review, and 96 studies were analyzed. The largest mapped focus was patients\u2019 access to guideline-based anticoagulation therapy (88\/96 articles, 91.7%). Seventy-eight articles made statistical outcomes comparisons among ethnoracial groups. Across all four research questions, 79 articles demonstrated favorable outcomes for White patients compared to non-White patients, 38 articles showed no difference between White and non-White groups, and 8 favored non-White groups (the total exceeds the 78 articles with statistical outcomes as many articles reported multiple outcomes). Disparities disadvantaging non-White patients were most pronounced in access to guideline-based anticoagulation therapy (43\/66 articles analyzed) and quality of anticoagulation management (19\/21 articles analyzed). Although treatment guidelines do not differentiate anticoagulant therapy by ethnoracial group, this scoping review found consistently favorable outcomes for White patients over non-White patients in the domains of access to anticoagulation therapy for guideline-based indications and quality of anticoagulation therapy management. No differences among groups were noted in clinical outcomes, and very few studies assessed humanistic or educational outcomes.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>\n                <jats:p>Scoping Review: Differences in quality of United States anticoagulation care delivery by ethnoracial group. AF\u2009=\u2009atrial fibrillation; AMS\u2009=\u2009anticoagulation management service; DOACs\u2009=\u2009direct oral anticoagulants; INR\u2009=\u2009international normalized ratio; PSM\u2009=\u2009patient self-management; PST\u2009=\u2009patient self-testing<\/jats:p>","DOI":"10.1007\/s11239-024-02991-2","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T15:01:18Z","timestamp":1715439678000},"page":"1076-1091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differences in quality of anticoagulation care delivery according to ethnoracial group in the United States: A scoping review"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-8980","authenticated-orcid":false,"given":"Sara R.","family":"Vazquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi Y.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig J.","family":"Beavers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren M.","family":"Triller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"issue":"1","key":"2991_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ogc.2016.10.001","volume":"44","author":"SM Wheeler","year":"2017","unstructured":"Wheeler SM, Bryant AS (2017) Racial and Ethnic Disparities in Health and Health Care. Obstet Gynecol Clin North Am 44(1):1\u201311","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"3","key":"2991_CR2","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1111\/1475-6773.12705","volume":"53","author":"JI Manuel","year":"2018","unstructured":"Manuel JI (2018) Racial\/Ethnic and Gender Disparities in Health Care Use and Access. Health Serv Res 53(3):1407\u20131429","journal-title":"Health Serv Res"},{"issue":"1","key":"2991_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.thorsurg.2021.09.005","volume":"32","author":"MF Nadeem","year":"2022","unstructured":"Nadeem MF, Kaiser LR (2022) Disparities in Health Care Delivery Systems. Thorac Surg Clin 32(1):13\u201321","journal-title":"Thorac Surg Clin"},{"issue":"9","key":"2991_CR4","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1001\/jamainternmed.2021.3922","volume":"181","author":"J Wallace","year":"2021","unstructured":"Wallace J et al (2021) Changes in Racial and Ethnic Disparities in Access to Care and Health Among US Adults at Age 65 Years. JAMA Intern Med 181(9):1207\u20131215","journal-title":"JAMA Intern Med"},{"issue":"24","key":"2991_CR5","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1161\/CIR.0000000000000936","volume":"142","author":"K Churchwell","year":"2020","unstructured":"Churchwell K et al (2020) Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association. Circulation 142(24):e454\u2013e468","journal-title":"Circulation"},{"issue":"5","key":"2991_CR6","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s10840-022-01383-x","volume":"66","author":"SE Gomez","year":"2023","unstructured":"Gomez SE et al (2023) Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control. J Interv Card Electrophysiol 66(5):1279\u20131290","journal-title":"J Interv Card Electrophysiol"},{"issue":"12 Suppl","key":"2991_CR7","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1016\/j.cjco.2021.09.004","volume":"3","author":"KP Tamirisa","year":"2021","unstructured":"Tamirisa KP et al (2021) Racial and Ethnic Differences in the Management of Atrial Fibrillation. CJC Open 3(12 Suppl):S137\u2013S148","journal-title":"CJC Open"},{"issue":"2","key":"2991_CR8","doi-asserted-by":"publisher","first-page":"e210247","DOI":"10.1001\/jamanetworkopen.2021.0247","volume":"4","author":"LA Eberly","year":"2021","unstructured":"Eberly LA et al (2021) Racial\/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation. JAMA Netw Open 4(2):e210247","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2991_CR9","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.hrthm.2018.05.019","volume":"15","author":"FE Ugowe","year":"2018","unstructured":"Ugowe FE, Jackson LR, Thomas KL (2018) Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review. Heart Rhythm 15(9):1337\u20131345","journal-title":"Heart Rhythm"},{"issue":"1","key":"2991_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/jth.15140","volume":"19","author":"Y Xu","year":"2021","unstructured":"Xu Y, Siegal DM, Anand SS (2021) Ethnoracial variations in venous thrombosis: Implications for management, and a call to action. J Thromb Haemost 19(1):30\u201340","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2991_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ccd.29487","volume":"98","author":"I Erinne","year":"2021","unstructured":"Erinne I et al (2021) Racial disparities in the treatment of aortic stenosis: Has transcatheter aortic valve replacement bridged the gap? Catheter Cardiovasc Interv 98(1):148\u2013156","journal-title":"Catheter Cardiovasc Interv"},{"key":"2991_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.carrev.2021.06.120","volume":"37","author":"A Ali","year":"2022","unstructured":"Ali A et al (2022) Racial and Ethnic Disparities in the Use of Transcatheter Aortic Valve Replacement in the State of Connecticut. Cardiovasc Revasc Med 37:7\u201312","journal-title":"Cardiovasc Revasc Med"},{"issue":"5","key":"2991_CR13","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.jtcvs.2021.11.096","volume":"165","author":"MJ Pienta","year":"2023","unstructured":"Pienta MJ et al (2023) Racial disparities in mitral valve surgery: A statewide analysis. J Thorac Cardiovasc Surg 165(5):1815-1823.e8","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"15","key":"2991_CR14","doi-asserted-by":"publisher","first-page":"e012125","DOI":"10.1161\/JAHA.119.012125","volume":"8","author":"M Alkhouli","year":"2019","unstructured":"Alkhouli M et al (2019) Racial Disparities in the Utilization and Outcomes of Structural Heart Disease Interventions in the United States. J Am Heart Assoc 8(15):e012125","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2991_CR15","doi-asserted-by":"publisher","first-page":"e007698","DOI":"10.1161\/CIRCEP.119.007698","volume":"13","author":"SR Heckbert","year":"2020","unstructured":"Heckbert SR et al (2020) Differences by Race\/Ethnicity in the Prevalence of Clinically Detected and Monitor-Detected Atrial Fibrillation: MESA. Circ Arrhythm Electrophysiol 13(1):e007698","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"14","key":"2991_CR16","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1161\/CIRCULATIONAHA.113.006472","volume":"129","author":"NA Zakai","year":"2014","unstructured":"Zakai NA et al (2014) Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation 129(14):1502\u20131509","journal-title":"Circulation"},{"issue":"24","key":"2991_CR17","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.jacc.2021.04.109","volume":"78","author":"JA Lamprea-Montealegre","year":"2021","unstructured":"Lamprea-Montealegre JA et al (2021) Valvular Heart Disease in Relation to Race and Ethnicity: JACC Focus Seminar 4\/9. J Am Coll Cardiol 78(24):2493\u20132504","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2991_CR18","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/ehjcvp\/pvac040","volume":"8","author":"J Tamargo","year":"2022","unstructured":"Tamargo J et al (2022) Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events. Eur Heart J Cardiovasc Pharmacother 8(7):738\u2013751","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"1","key":"2991_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/jpm9010007","volume":"9","author":"SH Kanuri","year":"2019","unstructured":"Kanuri SH, Kreutz RP (2019) Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants. J Pers Med 9(1):7","journal-title":"J Pers Med"},{"key":"2991_CR20","doi-asserted-by":"publisher","unstructured":"Craig TJ, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland CJ Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie LK, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW (2019) Circulation 140 (2):e125\u2013e151. https:\/\/doi.org\/10.1161\/CIR.000000000000066","DOI":"10.1161\/CIR.000000000000066"},{"issue":"19","key":"2991_CR21","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","volume":"4","author":"TL Ortel","year":"2020","unstructured":"Ortel TL et al (2020) American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 4(19):4693\u20134738","journal-title":"Blood Adv"},{"issue":"6","key":"2991_CR22","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","volume":"160","author":"SM Stevens","year":"2021","unstructured":"Stevens SM et al (2021) Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest 160(6):e545\u2013e608","journal-title":"Chest"},{"issue":"22","key":"2991_CR23","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","volume":"2","author":"HJ Sch\u00fcnemann","year":"2018","unstructured":"Sch\u00fcnemann HJ et al (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv 2(22):3198\u20133225","journal-title":"Blood Adv"},{"issue":"5","key":"2991_CR24","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM et al (2021) 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143(5):e72\u2013e227","journal-title":"Circulation"},{"key":"2991_CR25","volume-title":"Office of Disease Prevention and Health Promotion","author":"National Action Plan for Adverse Drug Event Prevention","year":"2014","unstructured":"National Action Plan for Adverse Drug Event Prevention (2014) Office of Disease Prevention and Health Promotion. US Department of Health and Human Services, Washington, DC"},{"issue":"4","key":"2991_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jvsv.2022.03.003","volume":"10","author":"S Bhakta","year":"2022","unstructured":"Bhakta S et al (2022) A systematic review and meta-analysis of racial disparities in deep vein thrombosis and pulmonary embolism events in patients hospitalized with coronavirus disease 2019. J Vasc Surg Venous Lymphat Disord 10(4):939-944.e3","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"10","key":"2991_CR27","first-page":"1235","volume":"100","author":"G Corbie-Smith","year":"2008","unstructured":"Corbie-Smith G et al (2008) Conceptualizing race in research. J Natl Med Assoc 100(10):1235\u20131243","journal-title":"J Natl Med Assoc"},{"key":"2991_CR28","doi-asserted-by":"publisher","unstructured":"Vazquez SR, Yates NYY, McFarland MM (2022). Differences in anticoagulant care delivery according to ethnoracial group in the United States: a scoping review protocol. Open Sci Fram osf.io\/eydsa. https:\/\/doi.org\/10.17605\/OSF.IO\/9SE7H","DOI":"10.17605\/OSF.IO\/9SE7H"},{"key":"2991_CR29","doi-asserted-by":"crossref","unstructured":"Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H (2020) Joanna briggs institute reviewer's manual. Aromataris E, Munn Z (eds). Publisher: Joanna briggs institute. Chapter: chapter 11: scoping reviews","DOI":"10.46658\/JBIRM-20-01"},{"issue":"1","key":"2991_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8(1):19\u201332","journal-title":"Int J Soc Res Methodol"},{"issue":"1","key":"2991_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","volume":"10","author":"ML Rethlefsen","year":"2021","unstructured":"Rethlefsen ML et al (2021) PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Syst Rev 10(1):39","journal-title":"Syst Rev"},{"issue":"2","key":"2991_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA et al (2009) Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381","journal-title":"J Biomed Inform"},{"key":"2991_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J et al (2016) PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J Clin Epidemiol 75:40\u201346","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2991_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","volume":"149","author":"C Kearon","year":"2016","unstructured":"Kearon C et al (2016) Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 149(2):315\u2013352","journal-title":"Chest"},{"issue":"5","key":"2991_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","volume":"154","author":"GYH Lip","year":"2018","unstructured":"Lip GYH et al (2018) Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report. Chest 154(5):1121\u20131201","journal-title":"Chest"},{"key":"2991_CR36","volume-title":"Boston","author":"al Taii, H. and S. Al-Kindi, Racial disparities in prescriptions of oral anticoagulants among patients with atrial fibrillation., in 24th International Atrial Fibrillation Symposium","year":"2019","unstructured":"al Taii, H. and S. Al-Kindi, Racial disparities in prescriptions of oral anticoagulants among patients with atrial fibrillation., in 24th International Atrial Fibrillation Symposium (2019) Boston. MA, USA"},{"issue":"7","key":"2991_CR37","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.hrthm.2015.03.031","volume":"12","author":"PD Bhave","year":"2015","unstructured":"Bhave PD et al (2015) Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm 12(7):1406\u20131412","journal-title":"Heart Rhythm"},{"issue":"1","key":"2991_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12913-017-2025-6","volume":"17","author":"SA Chapman","year":"2017","unstructured":"Chapman SA et al (2017) Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS. BMC Health Serv Res 17(1):127","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"2991_CR39","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/jcpt.13508","volume":"46","author":"Q Chen","year":"2021","unstructured":"Chen Q et al (2021) Prevalence and the factors associated with oral anticoagulant use among nursing home residents. J Clin Pharm Ther 46(6):1714\u20131728","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"2991_CR40","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1080\/13696998.2020.1832099","volume":"23","author":"S Deitelzweig","year":"2020","unstructured":"Deitelzweig S et al (2020) Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA. J Med Econ 23(12):1389\u20131400","journal-title":"J Med Econ"},{"issue":"12","key":"2991_CR41","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1001\/jamacardio.2018.3945","volume":"3","author":"UR Essien","year":"2018","unstructured":"Essien UR et al (2018) Association of Race\/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II. JAMA Cardiol 3(12):1174\u20131182","journal-title":"JAMA Cardiol"},{"issue":"7","key":"2991_CR42","doi-asserted-by":"publisher","first-page":"e2114234","DOI":"10.1001\/jamanetworkopen.2021.14234","volume":"4","author":"UR Essien","year":"2021","unstructured":"Essien UR et al (2021) Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race\/Ethnicity Among Patients in the Veterans Health Administration System. JAMA Netw Open 4(7):e2114234","journal-title":"JAMA Netw Open"},{"key":"2991_CR43","doi-asserted-by":"crossref","unstructured":"Essien UR, Kim N, Hausmann LR, Mor MK, Good C, Gellad WF, Fine MJ (2020) Abstract: racial and ethnic disparities in anticoagulant choice for atrial fibrillation in the veterans health administration: results from the reach-af study. J Gen Int Med J 35(1):S250\u2013251","DOI":"10.1161\/hcq.13.suppl_1.231"},{"issue":"2","key":"2991_CR44","doi-asserted-by":"publisher","first-page":"e008389","DOI":"10.1161\/CIRCOUTCOMES.121.008389","volume":"15","author":"UR Essien","year":"2022","unstructured":"Essien UR et al (2022) Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities. Circ Cardiovasc Qual Outcomes 15(2):e008389","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"2991_CR45","first-page":"103","volume":"112","author":"UR Essien","year":"2020","unstructured":"Essien UR et al (2020) Race\/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data. J Natl Med Assoc 112(1):103\u2013108","journal-title":"J Natl Med Assoc"},{"issue":"11","key":"2991_CR46","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/jgs.15058","volume":"65","author":"RB Fohtung","year":"2017","unstructured":"Fohtung RB, Novak E, Rich MW (2017) Effect of New Oral Anticoagulants on Prescribing Practices for Atrial Fibrillation in Older Adults. J Am Geriatr Soc 65(11):2405\u20132412","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"2991_CR47","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ahj.2011.07.019","volume":"162","author":"WR Lewis","year":"2011","unstructured":"Lewis WR et al (2011) Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-Stroke. Am Heart J 162(4):692-699.e2","journal-title":"Am Heart J"},{"issue":"8","key":"2991_CR48","first-page":"e17392","volume":"13","author":"C Martin Diaz","year":"2021","unstructured":"Martin Diaz C et al (2021) Anticoagulation After Ischemic Stroke or Transient Ischemic Attack (TIA) in the Time of Direct Oral Anticoagulation (DOAC) and Thrombectomy. Cureus 13(8):e17392","journal-title":"Cureus"},{"issue":"17","key":"2991_CR49","doi-asserted-by":"publisher","first-page":"e021674","DOI":"10.1161\/JAHA.121.021674","volume":"10","author":"A Mentias","year":"2021","unstructured":"Mentias A et al (2021) Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter. J Am Heart Assoc 10(17):e021674","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"2991_CR50","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s11239-021-02555-8","volume":"53","author":"CA Obi","year":"2022","unstructured":"Obi CA et al (2022) Examination of anticoagulation prescription among elderly patients with atrial fibrillation after in-hospital fall. J Thromb Thrombolysis 53(3):683\u2013689","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"2991_CR51","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1161\/CIRCULATIONAHA.118.035909","volume":"139","author":"JP Piccini","year":"2019","unstructured":"Piccini JP et al (2019) Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable. Circulation 139(12):1497\u20131506","journal-title":"Circulation"},{"issue":"1","key":"2991_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1345\/aph.1R515","volume":"47","author":"MA Raji","year":"2013","unstructured":"Raji MA et al (2013) National utilization patterns of warfarin use in older patients with atrial fibrillation: a population-based study of Medicare Part D beneficiaries. Ann Pharmacother 47(1):35\u201342","journal-title":"Ann Pharmacother"},{"issue":"12","key":"2991_CR53","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.amjcard.2019.03.020","volume":"123","author":"SM Schwartz","year":"2019","unstructured":"Schwartz SM et al (2019) Discriminative Ability of CHA. Am J Cardiol 123(12):1949\u20131954","journal-title":"Am J Cardiol"},{"key":"2991_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.amjcard.2021.05.008","volume":"153","author":"I Shahid","year":"2021","unstructured":"Shahid I et al (2021) Meta-Analysis of Racial Disparity in Utilization of Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation. Am J Cardiol 153:147\u2013149","journal-title":"Am J Cardiol"},{"issue":"5","key":"2991_CR55","doi-asserted-by":"publisher","first-page":"104718","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104718","volume":"29","author":"YG Tedla","year":"2020","unstructured":"Tedla YG et al (2020) Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients. J Stroke Cerebrovasc Dis 29(5):104718","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"2991_CR56","doi-asserted-by":"publisher","first-page":"e000200","DOI":"10.1161\/JAHA.113.000200","volume":"2","author":"KL Thomas","year":"2013","unstructured":"Thomas KL et al (2013) Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure. J Am Heart Assoc 2(5):e000200","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"2991_CR57","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1681\/ASN.2019050543","volume":"31","author":"SP Waddy","year":"2020","unstructured":"Waddy SP et al (2020) Racial\/Ethnic Disparities in Atrial Fibrillation Treatment and Outcomes among Dialysis Patients in the United States. J Am Soc Nephrol 31(3):637\u2013649","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2991_CR58","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.amjcard.2018.11.020","volume":"123","author":"JB Wetmore","year":"2019","unstructured":"Wetmore JB et al (2019) Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis. Am J Cardiol 123(4):598\u2013604","journal-title":"Am J Cardiol"},{"issue":"3","key":"2991_CR59","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5301\/jn.5000010","volume":"25","author":"WC Winkelmayer","year":"2012","unstructured":"Winkelmayer WC et al (2012) Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol 25(3):341\u2013353","journal-title":"J Nephrol"},{"issue":"1","key":"2991_CR60","first-page":"111","volume":"10","author":"DB Zahuranec","year":"2017","unstructured":"Zahuranec DB et al (2017) Stroke Quality Measures in Mexican Americans and Non-Hispanic Whites. J Health Dispar Res Pract 10(1):111\u2013123","journal-title":"J Health Dispar Res Pract"},{"issue":"2","key":"2991_CR61","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/COC.0000000000000639","volume":"43","author":"NO Addo-Tabiri","year":"2020","unstructured":"Addo-Tabiri NO et al (2020) Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism. Am J Clin Oncol 43(2):94\u2013100","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"2991_CR62","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ygyno.2016.06.002","volume":"142","author":"AH Freeman","year":"2016","unstructured":"Freeman AH et al (2016) Venous thromboembolism following minimally invasive surgery among women with endometrial cancer. Gynecol Oncol 142(2):267\u2013272","journal-title":"Gynecol Oncol"},{"issue":"6","key":"2991_CR63","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/AOG.0000000000000007","volume":"122","author":"AM Friedman","year":"2013","unstructured":"Friedman AM et al (2013) Underuse of postcesarean thromboembolism prophylaxis. Obstet Gynecol 122(6):1197\u20131204","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2991_CR64","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/MLR.0000000000000251","volume":"53","author":"BD Lau","year":"2015","unstructured":"Lau BD et al (2015) Eliminating Health Care Disparities With Mandatory Clinical Decision Support: The Venous Thromboembolism (VTE) Example. Med Care 53(1):18\u201324","journal-title":"Med Care"},{"issue":"1","key":"2991_CR65","doi-asserted-by":"publisher","first-page":"e0227339","DOI":"10.1371\/journal.pone.0227339","volume":"15","author":"OP Owodunni","year":"2020","unstructured":"Owodunni OP et al (2020) Using electronic health record system triggers to target delivery of a patient-centered intervention to improve venous thromboembolism prevention for hospitalized patients: Is there a differential effect by race? PLoS ONE 15(1):e0227339","journal-title":"PLoS ONE"},{"issue":"11","key":"2991_CR66","doi-asserted-by":"publisher","first-page":"e30743","DOI":"10.2196\/30743","volume":"9","author":"S Shah","year":"2021","unstructured":"Shah S et al (2021) Implementation of an Anticoagulation Practice Guideline for COVID-19 via a Clinical Decision Support System in a Large Academic Health System and Its Evaluation: Observational Study. JMIR Med Inform 9(11):e30743","journal-title":"JMIR Med Inform"},{"issue":"6","key":"2991_CR67","doi-asserted-by":"publisher","first-page":"e000535","DOI":"10.1161\/JAHA.113.000535","volume":"2","author":"BA Steinberg","year":"2013","unstructured":"Steinberg BA et al (2013) Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation. J Am Heart Assoc 2(6):e000535","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"2991_CR68","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.amjmed.2014.07.024","volume":"127","author":"MS Vaughan Sarrazin","year":"2014","unstructured":"Vaughan Sarrazin MS et al (2014) Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran. Am J Med 127(12):1179\u20131185","journal-title":"Am J Med"},{"issue":"4","key":"2991_CR69","doi-asserted-by":"publisher","first-page":"e005600","DOI":"10.1161\/CIRCOUTCOMES.119.005600","volume":"12","author":"AS Nathan","year":"2019","unstructured":"Nathan AS et al (2019) Racial, Ethnic, and Socioeconomic Inequities in the Prescription of Direct Oral Anticoagulants in Patients With Venous Thromboembolism in the United States. Circ Cardiovasc Qual Outcomes 12(4):e005600","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2991_CR70","unstructured":"Singh BP, Sitlinger A, Saber I, Thames E, Beckman M, Reyes N, Schulteis RD, Ortel T (2016) Direct oral anticoagulant usage in the treatment of venous thromboembolism across racial groups in Durham County, NC. J Gen Int Med 31:S191\u2013S192"},{"issue":"26","key":"2991_CR71","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1182\/bloodadvances.2017012377","volume":"1","author":"JK Schaefer","year":"2017","unstructured":"Schaefer JK et al (2017) Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants. Blood Adv 1(26):2536\u20132540","journal-title":"Blood Adv"},{"issue":"6","key":"2991_CR72","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/STROKEAHA.118.024249","volume":"50","author":"RJ Lank","year":"2019","unstructured":"Lank RJ et al (2019) Ethnic Differences in 90-Day Poststroke Medication Adherence. Stroke 50(6):1519\u20131524","journal-title":"Stroke"},{"key":"2991_CR73","doi-asserted-by":"crossref","unstructured":"O'Brien EC, Holmes ND, Thomas L, Fonarow GC, Kowey PR, Ansell JE, Mahaffey KW, Gersh BJ, Peterson ED, Piccini JP, Hylek EM (2018) J Am Heart Assoc 7(12):e006391","DOI":"10.1161\/JAHA.117.006391"},{"issue":"3","key":"2991_CR74","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/1076029615601493","volume":"22","author":"RR Singh","year":"2016","unstructured":"Singh RR et al (2016) Adherence to Anticoagulant Therapy in Pediatric Patients Hospitalized With Pulmonary Embolism or Deep Vein Thrombosis: A Retrospective Cohort Study. Clin Appl Thromb Hemost 22(3):260\u2013264","journal-title":"Clin Appl Thromb Hemost"},{"key":"2991_CR75","unstructured":"Yong C, Xu XY, Than C, Ullal A, Schmitt S, Azarbal F, Heidenreich P, Turakhia M (2013) Abstract 14134: racial disparities in warfarin time in INR therapeutic range in patients with atrial fibrillation: Findings from the TREAT-AF Study. Circul 128(22).\u00a0https:\/\/www.ahajournals.org\/doi\/10.1161\/circ.128.suppl_22.A14134"},{"issue":"2","key":"2991_CR76","doi-asserted-by":"publisher","first-page":"e1921357","DOI":"10.1001\/jamanetworkopen.2019.21357","volume":"3","author":"N Chen","year":"2020","unstructured":"Chen N, Brooks MM, Hernandez I (2020) Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation. JAMA Netw Open 3(2):e1921357","journal-title":"JAMA Netw Open"},{"issue":"6","key":"2991_CR77","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.japh.2020.08.004","volume":"60","author":"TP Pham Nguyen","year":"2003","unstructured":"Pham Nguyen TP et al (2003) Does hospitalization for thromboembolism improve oral anticoagulant adherence in patients with atrial fibrillation? J Am Pharm Assoc 60(6):986-992.e2","journal-title":"J Am Pharm Assoc"},{"issue":"11","key":"2991_CR78","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.clinthera.2013.09.010","volume":"35","author":"AA Patel","year":"2013","unstructured":"Patel AA et al (2013) Persistence of warfarin therapy for residents in long-term care who have atrial fibrillation. Clin Ther 35(11):1794\u20131804","journal-title":"Clin Ther"},{"key":"2991_CR79","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ahj.2015.10.028","volume":"174","author":"H Golwala","year":"2016","unstructured":"Golwala H et al (2016) Racial\/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. Am Heart J 174:29\u201336","journal-title":"Am Heart J"},{"issue":"10","key":"2991_CR80","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/FPC.0000000000000298","volume":"27","author":"NA Limdi","year":"2017","unstructured":"Limdi NA et al (2017) Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users. Pharmacogenet Genomics 27(10):347\u2013355","journal-title":"Pharmacogenet Genomics"},{"issue":"11","key":"2991_CR81","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.amjcard.2016.08.047","volume":"118","author":"GY Lip","year":"2016","unstructured":"Lip GY et al (2016) Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT). Am J Cardiol 118(11):1680\u20131684","journal-title":"Am J Cardiol"},{"issue":"3","key":"2991_CR82","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/1062860614526282","volume":"30","author":"SR Rao","year":"2015","unstructured":"Rao SR et al (2015) Explaining racial disparities in anticoagulation control: results from a study of patients at the Veterans Administration. Am J Med Qual 30(3):214\u2013222","journal-title":"Am J Med Qual"},{"key":"2991_CR83","unstructured":"Thigpen JL, Yah Q, Beasley M, Limdi NA (2012) Abstract: racial differences in anticoagulation control and risk of hemorrhage among warfarin users. Pharmacoth 32(10):E189"},{"issue":"1","key":"2991_CR84","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.amjcard.2015.09.047","volume":"117","author":"C Yong","year":"2016","unstructured":"Yong C et al (2016) Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study). Am J Cardiol 117(1):61\u201368","journal-title":"Am J Cardiol"},{"issue":"9","key":"2991_CR85","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/pbc.24546","volume":"60","author":"BS Moffett","year":"2013","unstructured":"Moffett BS, Kim S, Bomgaars LR (2013) Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge. Pediatr Blood Cancer 60(9):1503\u20131506","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2991_CR86","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1378\/chest.12-1119","volume":"143","author":"AJ Rose","year":"2013","unstructured":"Rose AJ et al (2013) Gaps in monitoring during oral anticoagulation: insights into care transitions, monitoring barriers, and medication nonadherence. Chest 143(3):751\u2013757","journal-title":"Chest"},{"issue":"8","key":"2991_CR87","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00246-011-9984-x","volume":"32","author":"WT Mahle","year":"2011","unstructured":"Mahle WT et al (2011) Management of warfarin in children with heart disease. Pediatr Cardiol 32(8):1115\u20131119","journal-title":"Pediatr Cardiol"},{"issue":"15","key":"2991_CR88","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.2146\/ajhp100562","volume":"68","author":"M Meade","year":"2011","unstructured":"Meade M et al (2011) Impact of health disparities on staff workload in pharmacist-managed anticoagulation clinics. Am J Health Syst Pharm 68(15):1430\u20131435","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"2991_CR89","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/14779072.2021.2013816","volume":"19","author":"F Aguilar","year":"2021","unstructured":"Aguilar F et al (2021) Off-label direct oral anticoagulants dosing in atrial fibrillation and venous thromboembolism is associated with higher mortality. Expert Rev Cardiovasc Ther 19(12):1119\u20131126","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"2991_CR90","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5847\/wjem.j.1920-8642.2018.03.006","volume":"9","author":"SP Jellinek-Cohen","year":"2018","unstructured":"Jellinek-Cohen SP, Li M, Husk G (2018) Enoxaparin dosing errors in the emergency department. World J Emerg Med 9(3):195\u2013202","journal-title":"World J Emerg Med"},{"issue":"5","key":"2991_CR91","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10900-015-0066-5","volume":"40","author":"DM Triller","year":"2015","unstructured":"Triller DM et al (2015) Trends in Warfarin Monitoring Practices Among New York Medicare Beneficiaries, 2006\u20132011. J Community Health 40(5):845\u2013854","journal-title":"J Community Health"},{"key":"2991_CR92","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijcard.2020.06.032","volume":"320","author":"T Akhtar","year":"2020","unstructured":"Akhtar T et al (2020) Factors associated with bleeding events in patients on rivaroxaban for non-valvular atrial fibrillation: A real-world experience. Int J Cardiol 320:78\u201382","journal-title":"Int J Cardiol"},{"issue":"1","key":"2991_CR93","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jvsv.2021.05.007","volume":"10","author":"RS Cires-Drouet","year":"2022","unstructured":"Cires-Drouet RS et al (2022) Prevalence and clinical outcomes of hospitalized patients with upper extremity deep vein thrombosis. J Vasc Surg Venous Lymphat Disord 10(1):102\u2013110","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"2991_CR94","doi-asserted-by":"publisher","first-page":"3890706","DOI":"10.1155\/2020\/3890706","volume":"2020","author":"K Doucette","year":"2020","unstructured":"Doucette K et al (2020) Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese. Adv Hematol 2020:3890706","journal-title":"Adv Hematol"},{"key":"2991_CR95","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijcard.2020.12.064","volume":"329","author":"K Gu","year":"2021","unstructured":"Gu K et al (2021) Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR\u00ae PINNACLE Registry. Int J Cardiol 329:209\u2013216","journal-title":"Int J Cardiol"},{"key":"2991_CR96","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.thromres.2018.04.008","volume":"166","author":"Y Yamashita","year":"2018","unstructured":"Yamashita Y et al (2018) Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: A systemic review and meta-analysis. Thromb Res 166:37\u201342","journal-title":"Thromb Res"},{"issue":"2","key":"2991_CR97","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1160\/th15-06-0474","volume":"115","author":"M Di Nisio","year":"2016","unstructured":"Di Nisio M et al (2016) Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists. Thromb Haemost 115(2):424\u2013432","journal-title":"Thromb Haemost"},{"issue":"1","key":"2991_CR98","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1001\/jamainternmed.2014.5398","volume":"175","author":"I Hernandez","year":"2015","unstructured":"Hernandez I et al (2015) Risk of bleeding with dabigatran in atrial fibrillation. JAMA Intern Med 175(1):18\u201324","journal-title":"JAMA Intern Med"},{"issue":"2","key":"2991_CR99","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1160\/th15-04-0319","volume":"115","author":"A Majeed","year":"2016","unstructured":"Majeed A et al (2016) Bleeding events with dabigatran or warfarin in patients with venous thromboembolism. Thromb Haemost 115(2):291\u2013298","journal-title":"Thromb Haemost"},{"issue":"5","key":"2991_CR100","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/STROKEAHA.113.004506","volume":"45","author":"GJ Hankey","year":"2014","unstructured":"Hankey GJ et al (2014) Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke 45(5):1304\u20131312","journal-title":"Stroke"},{"issue":"5","key":"2991_CR101","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/TA.0000000000001414","volume":"82","author":"L Kobayashi","year":"2017","unstructured":"Kobayashi L et al (2017) Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial. J Trauma Acute Care Surg 82(5):827\u2013835","journal-title":"J Trauma Acute Care Surg"},{"key":"2991_CR102","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ahj.2021.12.017","volume":"247","author":"B Gencer","year":"2022","unstructured":"Gencer B et al (2022) Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups. Am Heart J 247:24\u201332","journal-title":"Am Heart J"},{"issue":"5","key":"2991_CR103","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40256-021-00476-8","volume":"21","author":"N Chen","year":"2021","unstructured":"Chen N et al (2021) Joint Latent Class Analysis of Oral Anticoagulation Use and Risk of Stroke or Systemic Thromboembolism in Patients with Atrial Fibrillation. Am J Cardiovasc Drugs 21(5):573\u2013580","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2","key":"2991_CR104","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.amjcard.2015.04.012","volume":"116","author":"R Kabra","year":"2015","unstructured":"Kabra R et al (2015) Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation. Am J Cardiol 116(2):230\u2013235","journal-title":"Am J Cardiol"},{"issue":"11","key":"2991_CR105","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s12325-018-0782-1","volume":"35","author":"MH Kim","year":"2018","unstructured":"Kim MH, Xu L, Puckrein G (2018) Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: An Analysis Using Administrative Claims Data. Adv Ther 35(11):2069\u20132080","journal-title":"Adv Ther"},{"issue":"2","key":"2991_CR106","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11239-019-01836-7","volume":"48","author":"G Abu-Zeinah","year":"2019","unstructured":"Abu-Zeinah G, Oromendia C, DeSancho MT (2019) Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience. J Thromb Thrombolysis 48(2):233\u2013239","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"2991_CR107","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12245-017-0144-9","volume":"10","author":"SR Banala","year":"2017","unstructured":"Banala SR et al (2017) Discharge or admit? Emergency department management of incidental pulmonary embolism in patients with cancer: a retrospective study. Int J Emerg Med 10(1):19","journal-title":"Int J Emerg Med"},{"issue":"4","key":"2991_CR108","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.surg.2019.04.039","volume":"166","author":"ZJ LaDuke","year":"2019","unstructured":"LaDuke ZJ et al (2019) Association of mortality among trauma patients taking preinjury direct oral anticoagulants versus vitamin K antagonists. Surgery 166(4):564\u2013571","journal-title":"Surgery"},{"issue":"1","key":"2991_CR109","first-page":"22","volume":"39","author":"CJ Moreland","year":"2013","unstructured":"Moreland CJ et al (2013) Anticoagulation education: do patients understand potential medication-related emergencies? Jt Comm J Qual Patient Saf 39(1):22\u201331","journal-title":"Jt Comm J Qual Patient Saf"},{"issue":"17","key":"2991_CR110","doi-asserted-by":"publisher","first-page":"e019979","DOI":"10.1161\/JAHA.120.019979","volume":"10","author":"BA Bamgbade","year":"2021","unstructured":"Bamgbade BA et al (2021) Differences in Perceived and Predicted Bleeding Risk in Older Adults With Atrial Fibrillation: The SAGE-AF Study. J Am Heart Assoc 10(17):e019979","journal-title":"J Am Heart Assoc"},{"key":"2991_CR111","doi-asserted-by":"publisher","first-page":"107602961986466","DOI":"10.1177\/1076029619864663","volume":"25","author":"D Webb","year":"2019","unstructured":"Webb D et al (2019) Patient Satisfaction With Venous Thromboembolism Treatment. Clin Appl Thromb Hemost 25:1076029619864663","journal-title":"Clin Appl Thromb Hemost"},{"issue":"7","key":"2991_CR112","doi-asserted-by":"publisher","first-page":"e2116009","DOI":"10.1001\/jamanetworkopen.2021.16009","volume":"4","author":"CC Kamath","year":"2021","unstructured":"Kamath CC et al (2021) Cost Conversations About Anticoagulation Between Patients With Atrial Fibrillation and Their Clinicians: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open 4(7):e2116009","journal-title":"JAMA Netw Open"},{"key":"2991_CR113","unstructured":"U.S. Census Bureau. [cited 2023 10\/20\/23]; Available from: https:\/\/www.census.gov\/quickfacts\/fact\/note\/US\/RHI625222#:~:text=Asian.,Japan%2C%20Korea%2C%20or%20Vietnam."},{"key":"2991_CR114","doi-asserted-by":"publisher","first-page":"106237","DOI":"10.1016\/j.cct.2020.106237","volume":"101","author":"KM Fain","year":"2021","unstructured":"Fain KM et al (2021) Race and ethnicity reporting for clinical trials in ClinicalTrials.gov and publications. Contemp Clin Trials 101:106237","journal-title":"Contemp Clin Trials"},{"key":"2991_CR115","unstructured":"American Psychological Association Ethnic and racial minorities & socioeconomic status. 3\/22\/24]; Available from: https:\/\/www.apa.org\/pi\/ses\/resources\/publications\/minorities#:~:text=The%20relationship%20between%20SES%2C%20race,SES%2C%20race%2C%20and%20ethnicity. Accessed 22 Mar 2024"},{"issue":"Suppl 1","key":"2991_CR116","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2105\/AJPH.2009.166082","volume":"100 Suppl 1","author":"PA Braveman","year":"2010","unstructured":"Braveman PA et al (2010) Socioeconomic disparities in health in the United States: what the patterns tell us. Am J Public Health 100 Suppl 1(Suppl 1):186\u201396","journal-title":"Am J Public Health"},{"issue":"12","key":"2991_CR117","doi-asserted-by":"publisher","first-page":"e2137288","DOI":"10.1001\/jamanetworkopen.2021.37288","volume":"4","author":"KM Wheelock","year":"2021","unstructured":"Wheelock KM et al (2021) Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries. JAMA Netw Open 4(12):e2137288","journal-title":"JAMA Netw Open"},{"issue":"12","key":"2991_CR118","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.amjmed.2015.05.044","volume":"128","author":"GD Barnes","year":"2015","unstructured":"Barnes GD et al (2015) National Trends in Ambulatory Oral Anticoagulant Use. Am J Med 128(12):1300\u20135.e2","journal-title":"Am J Med"},{"issue":"3","key":"2991_CR119","doi-asserted-by":"publisher","first-page":"e234059","DOI":"10.1001\/jamanetworkopen.2023.4059","volume":"6","author":"GS Iyer","year":"2023","unstructured":"Iyer GS et al (2023) Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010\u20132020. JAMA Netw Open 6(3):e234059","journal-title":"JAMA Netw Open"},{"key":"2991_CR120","unstructured":"MACRA Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). 03\/19\/24]; Available from: https:\/\/www.cms.gov\/medicare\/quality\/value-based-programs\/chip-reauthorization-act.\u00a0Accessed 19 Mar 2024"},{"key":"2991_CR121","unstructured":"Blueprint Measure Lifecycle Overview. 03\/19\/2024]; Available from: https:\/\/mmshub.cms.gov\/blueprint-measure-lifecycle-overview.\u00a0Accessed 19 Mar 2024"},{"key":"2991_CR122","unstructured":"Endorsement and Maintenance (E&M) Guidebook. 3\/19\/24]; Available from: https:\/\/p4qm.org\/sites\/default\/files\/2023-12\/Del-3-6-Endorsement-and-Maintenance-Guidebook-Final_0_0.pdf.\u00a0Accessed 19 Mar 2024"},{"key":"2991_CR123","unstructured":"Measure Implementation. 3\/19\/24]; Available from: https:\/\/mmshub.cms.gov\/measure-lifecycle\/measure-implementation\/selection.\u00a0Accessed 19 Mar 2024"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-02991-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-024-02991-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-02991-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T13:11:44Z","timestamp":1723209104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-024-02991-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":123,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["2991"],"URL":"https:\/\/doi.org\/10.1007\/s11239-024-02991-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,11]]},"assertion":[{"value":"27 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Vazquez discloses that she is a member of the Anticoagulation Forum Advisory Council and an editorial consultant for UptoDate, Inc.Dr. Yates has no conflicts of interest to disclose.Dr. Beavers has no conflicts of interest to disclose.Dr. Triller has no conflicts of interest to disclose.Ms. McFarland has no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}